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Human papillomavirus type 16 (HPV-16) is the major risk factor for development of cervical cancer. The major oncoprotein E7 enhances
cell growth control. However, E7 has in some reports been shown to induce apoptosis suggesting that there is a delicate balance between cell
proliferation and induction of cell death. We have used the osteosarcoma cell line U2OS cells provided with E7 and the cdk2 inhibitor p21
(cip1/waf1) under inducible control, as a model system for the analysis of E7-mediated apoptosis. Our data shows that simultaneous
expression of E7 and p21 proteins induces cell death, possibly because of conflicting growth control. Interestingly, E7/p21-induced cell death
is associated with the activation of a newly identified mediator of apoptosis, namely cathepsin B. Activation of the cellular caspases is
undetectable in cells undergoing E7/p21-induced apoptosis. To our knowledge, this is the first time a role for cathepsin B is reported in HPV-
induced apoptotic signalling.
D 2004 Elsevier Inc. All rights reserved.Keywords: Human papilloma virus; Apoptosis; Cathepsin BIntroduction
Several studies have indicated a tight coupling be-
tween excessive cellular proliferation and apoptosis, as
cell cycle regulators such as myc, E1A, E2F-1, cdc25,
and ras influence both events (reviewed in (Schmitt and
Lowe, 1999)).The transforming human papillomavirus
type 16 (HPV-16) E7 oncoprotein binds to and affects
the function of several cellular proteins involved in cell
cycle regulation and progression, among these pRb,
cyclin/cdk2 complexes and may be p21 (Funk et al.,
1997; Hickman et al., 1997; Tommasino et al., 1993, for
review, see Basile et al., 2001). Interestingly, E7 mediates
both pro- and anti-apoptotic effects. The pro-apoptotic0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.12.018
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E-mail address: bono@biobase.dk (B. Norrild).functions of E7 are shown by its ability to increase
spontaneous cell death (Pan and Griep, 1994; Stoppler
et al., 1998) as well as apoptosis induced by the tumor
necrosis factor (TNF) ligand family members (Basile et
al., 2001; Stoppler et al., 1998), sulfur mustard (Stoppler
et al., 1998), actinomycin D (Hickman et al., 1997), g-
radiation (Puthenveettil et al., 1996), and serum depriva-
tion (Jones et al., 1999). Not surprisingly, anti-apoptotic
effects of E7 have also been demonstrated (Lee et al.,
1998; Thompson et al., 2001). The mechanism by which
E7 promotes apoptosis is still dubious. It has been
suggested that E7, when inducing spontaneous cell death,
mediates its pro-apoptotic effect via a possible p53-
independent up-regulation of the inhibitory regulator of
the cell cycle p21cip/waf1 (p21) (Basile et al., 2001; Jian
et al., 1998, 1999; Jones et al., 1999; Park et al., 2000;
Stoppler et al., 1998). This hypothesis is supported by
the finding that introduction of p21 cDNA into HPV-16
and HPV-18 positive cancer cells induces apoptosis (Tsao
D.W. Kaznelson et al. / Virology 320 (2004) 301–312302et al., 1999). Data also show that inhibitors of the histone
deacetylase (HDAC-1) can provoke apoptosis in HPV-
infected cells through a mechanism where p21 is up-
regulated (Finzer et al., 2001).
In most models of cell demise, including HPV-induced
apoptosis, cell death is inevitably associated with the
activation of a family of cysteine proteases, the caspases
(Chang and Yang, 2000; Liu et al., 2000; Stoppler et al.,
1998). Especially, activation of the effector caspase-3 is
considered as an essential part of the classical apoptosis
pathway (Janicke et al., 1998; Porter and Janicke, 1999).
However, human MCF-7 breast carcinoma cells, not
expressing caspase-3, undergo apoptosis when exposed
to various apoptotic stimuli through other caspases (Eck-
Enriquez et al., 2000; Jaattela et al., 1996; Liang et al.,
2001), and hepatocytes as well as thymocytes undergo
caspase-3 independent apoptosis (Adjei et al., 1996;
Doerfler et al., 2000).
Indeed, other proteases than the caspases have been
shown to induce apoptotic signalling (Deiss et al., 1996;
Guicciardi et al., 2000; Ruggiero et al., 1987; Vanags et al.,
1996; Wright et al., 1994). One of them is the lysosomal
cathepsin B, a member of the cathepsin family consisting of
12 cysteine proteases with broad exo- and endopeptidase
activity (Guicciardi et al., 2000; Polgar and Csoma, 1987).
Interestingly, cathepsin B is commonly overexpressed in
human primary tumors and induces apoptosis both depen-
dent and independent of caspase activation. The same is true
for apoptosis induced in human hepatocytes by either
camptothecin (CPT) or bile-salt, where the apoptosis occur
independent or dependent of caspase-8, respectively (Adjei
et al., 1996; Roberts et al., 1999). Moreover, cathepsin B isFig. 1. Western blot analysis showing E7 and p21 protein expression levels and
endogenous p21 in E7/p21, E7, and p21 cell clones using E7 and p21 specific a
induced for 24, 48, and 72 h. (B) Comparison of expression levels of E7 in E
immunoprecipitation, using pRB-specific antibodies, of pRB with E7, verifying Ereported to act as a dominant execution protease, both
dependent and independent of caspases in death receptor
triggered tumor cell apoptosis (Foghsgaard et al., 2001).
Interestingly, during TNF-a induced apoptosis, cathepsin B
is released from the lysosomes to the cytosol where it,
possibly via Bid-mediated induction of cytochrome c re-
lease, engages traditional caspase activation (Foghsgaard et
al., 2001; Guicciardi et al., 2000; Mathiasen et al., 2001;
Stoka et al., 2001). Thus, active cathepsin B is a mediator of
apoptosis and its translocation to the cytosol is essential to
cell death.
The present study was initiated by our finding that
simultaneous HPV-16 E7 and p21 expression induces cell
death. Surprisingly, caspase-like protease activation was
undetectable in cells undergoing E7/p21-induced cell death.
This finding prompted us to search for non-caspase medi-
ators of apoptosis and resulted in the identification of
cathepsin B as a possible mediator of E7/p21-induced
apoptosis. Our study is the first reporting the involvement
of non-caspase mediators of apoptosis induced by the
introduction of a HPV oncogene.Results
Expression of E7 and p21 transgenes in U2OS cells
To study the influence of HPV-16 E7 and p21 on
apoptotic signaling, we developed a cell model system,
allowing simultaneous inducible expression of the trans-
forming HPV-16 E7 gene and the cdk inhibitor p21
(cip1/waf1) in U2OS cells. This was done by stablyfunctionality in U2OS cells. (A) Expression of E7, HA-tagged p21, and
ntibodies. Samples include an noninduced control marked C and samples
7 and E7/p21 cell clones with levels expressed in CaSki cells. (C) Co-
7 functionality in the E7 cell clone.
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carrying the genes of interest. Single-cell clones, resistant
to appropriate selection antibiotics, were analyzed for
transgene induction by analysis of E7 and p21 protein
expression in Western blot analysis. Massive amounts of
E7 and exogenous p21 protein were expressed in E7/p21,
E7, and p21 cell clones following protein induction (Fig.
1A). Moreover, the level of E7 expression in our model
system was compared to the level of E7 expression inFig. 2. Light microscopy showing changes in morphology of transgene U2OS c
apoptosis following 24–96 h of protein induction (B), E7/p21 noninduced control c
(D), E7 noninduced control cells (C). Enlarged p21 cells following protein inductCaSki cells naturally infected with HPV-16. Evidently,
the level of E7 expression in the E7/p21 and E7 cells
was higher than that present in CaSki cells (Fig. 1B).
The endogenous p21 level remained unchanged over
time. The intracellular localization of E7 and exogenous
p21 was studied by immunofluorescence. Both proteins
were expressed exclusively within the nucleus, suggesting
functionality of these two proteins when expressed in
U2OS cells (data not shown). To further ensure theell clones during protein induction. E7/p21 cells show extensive signs of
ells (A). E7 cells retain normal morphology following E7 protein expression
ion indicating cell cycle arrest (F), p21 noninduced control cells (E).
Fig. 4. (A) Incorporation of BrdU in p21 cells following protein induction.
Expression of p21 results in decreased incorporation of BrdU showing cell
cycle arrest in these cells. Bars indicate standard deviations for each time-
point measurement bases on three experiments. (B) Cell viability of E7/p21
cells measured by an MTT assay. The E7/p21 cell clone grew significantly
slower following protein induction as compared to noninduced cells.
Following 72 h of E7/p21 induction, the MTT measurement shows
apoptotic havoc in U2OS cells (solid squares). Noninduced control cells are
marked C. Bars indicate standard deviations calculated from readings of six
similar wells for each time point.
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analysis clearly showing coprecipitation of E7 and pRB
in the E7 cell line (Fig. 1C).
Simultaneous E7/p21 expression induces apoptosis
Upon protein induction, we first investigated the mor-
phology of the cells. Undoubtedly, E7/p21 expressing
cells showed apoptotic features such as membrane bleb-
bing (Fig. 2B). As expected, p21 overexpressing cells
showed signs of cell cycle arrest (Fig. 2F), whereas E7
expressing cells retained normal morphology (Fig. 2D).
Noninduced cells showed continued growth (Figs. 2A, C,
E). Simple protein determinations was used as a measure
of cell growth, and both E7/p21 and p21 expressing
cells showed reduced cell growth, whereas induced E7
cells exhibited the same growth increase as noninduced
controls (Fig. 3). The reduced cell growth of E7/p21
cells as well as stop of the cell cycle progression in the
p21 overexpressing cells was verified by the decreased
incorporation of bromdeoxyuridine (BrdU) in these cells
(Fig. 4A). The viability of E7/p21 expressing cells was
further measured using an MTT viability assay. As
compared to noninduced cells, the E7/p21 expressing
cells grew significantly slower for 72 h whereafter
apoptosis was initiated (Fig. 4B). To determine apoptosis
in induced E7/p21 cells, TUNEL analysis was performed
and a more than fourfold increase in the apoptotic index
clearly confirmed the morphological indications of apo-
ptosis in these cells (Figs. 5A, B). TUNEL analysis of
E7 and p21 expressing cells, respectively, revealed no
apoptosis above control levels in these cells (Figs. 5A,
B). TUNEL analysis of apoptosis induced in E7/p21
cells in the presence of the inhibitor of cathepsin B,
Ca-074 Me, showed a two- to threefold reduction in the
apoptotic index in the presence of the inhibitor (Fig.
5C). Annexin V staining of the noninduced and induced
E7/p21 cells 96 h following induction showed an in-Fig. 3. Protein quantification. A surrogate measure of cell growth. Simultaneous
Expressing E7 individually did not affect growth whereas induction of p21, inducincrease in apoptotic cells from 5% to 17%, while no
apoptosis was observed in the E7 and the p21 cell lines
(data not shown).expression of E7 and p21, due to apoptosis, resulted in decreased viability.
g cell cycle arrest, decreased growth. Noninduced control cells are marked C.
Fig. 6. Microscopy showing intracellular localization of Cathepsin B. (A and B) ca
cells. In (A), cells were immunostained using antibodies to cathepsin B followed b
the same primary antibody but followed by FITCH-conjugated secondary antibo
cytosol. All immunostainings were made by cathepsin B-specific rabbit serum pr
Fig. 5. TUNEL analysis. (A) Kinetics of the induction of apoptosis. The
experiment was performed twice with essentially the same results.
Noninduced control cells are marked C. (B) Percentage of apoptotic cells
following 48 h of induction of protein synthesis. (C) Percentage of
apoptotic cells following treatment with the Ca074-Me inhibitor during
induction of E7/p21 for up to 96 h. The apoptotic index in (B) and (C) is
expressed as a percentage of TUNEL-positive cells. (B) Columns represents
mean of three experiments and bars correspond to SD.
D.W. Kaznelson et al. / ViroloE7/p21-induced apoptosis is associated with translocation
and activation of cathepsin B
As the release of cathepsin B from lysosomes is
essential for its apoptotic capability, we investigated its
intracellular localization during E7/p21-induced apopto-
sis. To determine if cathepsin B is activated during E7/
p21-induced apoptosis, cells undergoing apoptosis were
examined by both cytochemistry and immunofluores-
cence (Fig. 6). Cathepsin B exhibits a granular staining
equivalent with lysosomal localization in noninduced
E7/p21 cells (Figs. 6A, B). Visibly, as shown by
immunofluorescence staining, cathepsin B is translocated
to the cytoplasm in U2OS cells undergoing E7/p21-
induced apoptosis (Fig. 6C). Cathepsin B is synthesized
as a catalytic inactive pre-pro-cathepsin B of 39 kDa.
Active cathepsin B consists of two alternate forms, one
single chain form of 30 kDa and a two chain form
consisting of a 5 and 26 kDa fragment (Chan et al.,
1986; Erickson, 1989). Western blot analysis of cell
extracts shows that E7/p21 expression induces increased
levels of cathepsin B in U2OS cells where the endog-
enous steady state level is rather low. Moreover, a shift
from catalytic inactive to active 26 kDa cathepsin B
was detected (Fig. 7A). Also, a minor increase of the
30 kDa active form of cathepsin B was detected
employing a cathepsin B-specific polyclonal rabbit se-
rum (Fig. 7B). It is recently reported that p21 may
regulate the expression of cathepsin B (Chang and
Yang, 2000). Thus, to evaluate whether cathepsin B
levels in E7/p21 expressing cells is dependent on p21
expression, p21 cells were analyzed for levels of
cathepsin B expression. Clearly, p21 expressing cells
express constant levels of cathepsin B following induc-
tion of p21 and no processing shift was detected either
(Fig. 7C). Thus, the rather high level of the 26kD
protein relates to the high level of protein loaded on
this particular gel. Moreover, no variation of cathepsin
B expression in noninduced E7, p21, or E7/p21 cell
clones was detected (data not shown).
gy 320 (2004) 301–312 305thepsin B is localized in lysosomal granular of untreated noninduced E7/p21
y peroxidase coupled secondary antibodies. In (B), cells were stained using
dy. (C) During E7/p21-induced apoptosis, cathepsin B is detected in the
ovided by Dr. E. Weber.
 Fig. 7. Western blot showing up-regulation and activation of cathepsin B
during E7/p21 expression. (A) E7/p21 expression induces up-regulation of
cathepsin B and a shift from in-active 39 kDa to active 26 kDa cathepsin B
as detected by using cathepsin B recognizing antibodies (Upstate
Biotechnologies Inc.). (B) E7/p21 expression also induces a minor up-
regulation of 30 kDa active cathepsin B as detected by using cathepsin B-
specific rabbit serum provided by Dr. E. Weber. (C) Induction of individual
p21 expression does not affect cathepsin B expression as detected by
cathepsin B recognizing antibodies (Upstate Biotechnologies Inc.). (D)
GAPDH is used as loading control. The amount of protein loaded per
sample was 3 times (40 Ag) of that loaded in (A) and (B).
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treated with the cathepsin B inhibitor Ca-074 Me during
induction show delay of cathepsin B activation. Activat-
ed cathepsin B protein appeared after 48 and 72 h of
treatment compared to activation of cathepsin B alreadyFig. 8. Western blot analysis of cathepsin B activation during 72 h induction of the
presence of 5 AM of the cathepsin B-specific inhibitor Ca-074 Me. Extracts fromat 24 h in nontreated induced E7/p21 cells (Fig. 8). This
corresponds well with the increase in the apoptotic index
of the Ca-074 Me treated cells at 48 and 72 h time
points (Fig. 5C). Thus, our data show that E7/p21-
induced apoptosis is associated with both translocation
and increased levels of active cathepsin B in U2OS
cells.
E7/p21-induced apoptosis is not associated with
caspase-like protease activation
Caspase-3 is considered a pivotal protease in apopto-
sis, and poly-(ADP-ribose)-polymerase (PARP) is a key
target for its activity. Therefore, we investigated both
caspase-3 activation and PARP cleavage following E7/
p21 induction. Analysis of caspase-3 enzyme activity in
E7/p21-induced cells shows no increase in the caspase-3
activity level (Fig. 9A). Camptothecin treated cells
served as a positive control showing massive caspase-
3 activation. According to Western blot analysis of pro-
caspase-3 and PARP in cell lysates from U2OS cells
undergoing E7/p21-induced apoptosis, no signs of cas-
pase-3 like activity was detected following up to 96 h of
protein induction (Fig. 9C). To investigate the ability of
U2OS cells to induce caspase-3 activation in response
to other apoptotic stimuli, noninduced E7/p21 cells were
treated for 24 h with various concentrations of etopo-
side, camptothecin, and actinomycin D. Etoposide treat-
ment induces both PARP cleavage and decreasing pro-
caspase-3 levels as measured in Western blot analysis
of cell lysates indicating its processing (Fig. 9B).
Similar results were obtained following camptothecin
and actinomycin D treatment (data not shown). Western
blot analysis of caspases being activated through mito-
chondrial-, or stress-induced pathways, namely caspase-
1, 7, and 8, in E7/p21-induced cells, shows no activa-
tion of these caspases (Figs. 9C, D). Unfortunately,
caspase-9 was not detectable in U2OS cells. As cas-E7/p21 proteins. The extracts were prepared also from cells induced in the
noninduced cells are marked C. GAPDH was used as loading control.
Fig. 9. (A) Caspase-3 enzyme activity measured in E7/p21 noninduced and induced cells. The activity was measured at 24, 48, 72, and 96 h after induction. The
caspase-3 inducer camptothecin (10 AM) was used for treatment of control cells for 24 h. The activity was measured in duplicates and the data are presented as
the mean value. (B) Western blot showing levels of PARP and pro-caspase processing in E7/p21 cells. Noninduced E7/p21 cells treated with indicated
concentrations of etoposide (Sigma) exhibit increased PARP and pro-caspase-3 processing as compared to untreated controls. (C, D) E7/p21 cells undergoing
apoptosis show no PARP, pro-caspase-3, pro-caspase-7, pro-caspase-8, or pro-caspase-1 processing. For detection of PARP, caspase-3, caspase-7, caspase-8,
and caspase-1 antibodies specific for these proteins were used. GAPDH is used as loading control.
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induced apoptosis, our data indicate that this particular
signalling pathway is mediated by cathepsin B and cas-
pase independent.Discussion
The data presented above show that simultaneous
HPV-16 E7 and p21 expression induces cell death.
D.W. Kaznelson et al. / Virology 320 (2004) 301–312308Moreover, we are the first to demonstrate that this HPV-
related apoptosis is associated with activation of cathepsin
B. The initiating apoptotic signal in E7/p21-induced cell
death must come from a lethal combination of E7 and
p21 expression, as our investigations show that none of
these proteins induce apoptosis when expressed individ-
ually. The E7 protein has in some studies shown to
sensitize cells to apoptosis after treatment with various
kinds of chemicals or irradiation (Basile et al., 2001;
Finzer et al., 2001; Hickman et al., 1997; Liu et al.,
2000; Stoppler et al., 1998).
Here we show that the E7/p21 protein expression by
itself induces cell death. In accordance with other models of
cell demise (Leist and Jaattela, 2001), we show that cathep-
sin B is released from the lysosomes to the cytosol during
apoptosis. Moreover, as judged from lack of PARP process-
ing as well as no activation of caspase-3 or other caspases in
E7/p21-induced apoptosis, this signalling pathway is not
associated with caspase activity. We suggest that induction
of caspase independent cell demise in our cell model system
is E7/p21 specific, as cell death induced by compounds such
as etoposide, camptothecin, and actinomycin D is associated
with the activation of at least the caspase-3 like proteases.
Thus, U2OS cells carry functional caspases, but apparently
they remain inactive during E7/p21-induced apoptosis. The
criteria and pathway for activating cathepsin B, rather than
caspases, in E7/p21-induced apoptosis remain speculative.
However, it is tempting to hypothesize that the caspases in
some way might be inhibited by E7/p21 expression. One
such inhibitory function has been reported for p21, as it by
N-terminal binding to pro-caspase-3 in Fas-treated human
hepatocytes, hinders caspase-3 maturation, and consequent-
ly apoptosis (Suzuki et al., 1998, 1999, 2000). However,
such possible caspase inhibitory role of p21 is not the only
function of p21 in E7/p21-induced apoptosis, as individual
expression of E7 does not induce apoptosis in our model
system. Thus, also an apoptosis promoting activity of p21 at
least in co-operation with E7 must exist. Adenovirus E1A,
which shares many biological functions with HPV-16 E7, is
reported to up-regulate caspase-7 and caspase-8 mediated
apoptosis through deregulation of E2F (Nahle et al., 2002).
HPV-16 E7 does not show the same caspase activation when
induced alone or together with p21.
Interestingly, cathepsin B has lately been speculated to
function as a backup program for cell death under patho-
logical conditions, where the caspase cascade is suspended
(Foghsgaard et al., 2001). Such suspension in, for example,
tumor cells may be a result of caspase mutations (Liang et
al., 2001; Soengas et al., 2001), overexpression of survival
proteins, for example, Bcl-2 (Tsujimoto and Croce, 1984),
or, as it may possibly be in the case of our study, elevated
p21 expression. Interestingly, cathepsin B is frequently up-
regulated in cancerous cells, probably to manage increased
protein turnover and invasiveness (MacKenzie et al., 2001).
In that sense, it would be an excellent default pathway to a
nonfunctional caspase cascade in cancer cells. This theory issupported by the fact that cathepsin B-mediated apoptosis
plays a more dominant role in cancerous than in primary
cells (Foghsgaard et al., 2001). The mechanism by which
cathepsin B function in apoptosis is not known. However, a
regulated transfer from the lysosomes to the cytosol and
nucleus seems to constitute a key role (Foghsgaard et al.,
2001; Roberts et al., 1999). Moreover, cathepsin B-mediated
cleavage of Bid, which following its processing promotes
caspase-dependent apoptosis by induction of cytochrome c
release, most likely constitute an amplification step in
apoptotic signalling (Mathiasen et al., 2001; Stoka et al.,
2001). However, our data, together with data published by
others, suggest that cathepsin B can possibly mediate
apoptosis even without activation of caspases at all (Adjei
et al., 1996; Foghsgaard et al., 2001; Roberts et al., 1999).
Therefore, other downstream targets of cathepsin B medi-
ating caspase-independent apoptosis must exist and await
further discovery.Materials and methods
Cell culture
The U2OS-Tet-Off cell line, which is human osteosar-
coma cells provided with a tetracycline-dependent expres-
sions vector system (Clontech), were cultured in complete
medium (CM) consisting of Dulbecco’s modified Eagle’s
1885 medium (DMEM) supplemented with 10% fetal calf
serum (FCS), 1% L-glutamine, and 1% penicillin/strepto-
mycin at 37 jC in humidified air atmosphere with 5% CO2.
Medium used for selection and culture of transfected cells
was further supplemented with appropriate antibiotics: 400
Ag/ml G418 (Invitrogen), 1 Ag/ml puromycin (Sigma), and
75 Ag/ml hygromycin B (RocheA/S). Cell lines were
regularly tested negative for infection with mycoplasma.
Construction of expression vectors
To create the E7 expression vector (pUHD10-3-E7), an
HPV-16 fragment from base pair position 505–875 of the
HPV genome containing the E7 open reading frame (base
pair 562–858) was inserted into the BamHI/EcoRI site in
the tetracycline responsive expression vector pUHD 10-3.
The expression vector carrying HA-tagged p21 (pUHD10-
3-p21HA) was provided by Dr. J. Lukas and Dr. J. Bartek,
The Danish Cancer Society, Division for Cancer Biology.
Establishment of U2OS cells with inducible HPV-16 E7 and
p21 expression
For the establishment of U2OS cells with inducible
expression of either E7 or p21, expression vectors
pUHD10-3-E7 and pUHD10-3-p21, respectively, were in-
troduced into U2OS-Tet-Off cells along with pBabepuro
(Morgenstern and Land, 1990) conferring pyromycin resis-
D.W. Kaznelson et al. / Virolotance. To establish U2OS cells inducible of simultaneous E7
and p21 expression, one clone successfully transfected with
pUHD10-3-p21 was selected and further provided with
pUHD10-3-E7 and pBabehygro conferring hygromycin
resistance. All transfections were performed using cells in
logarithmic growth phase and LipofectAmine Plus (Invitro-
gen) according to the manufacturer’s instructions. To avoid
constitutive expression of the transgenes, the culture media
was supplemented with 2 Ag/ml tetracycline (Sigma). Con-
fluent drug-resistant single-cell clones were collected and
propagated. Where specified in the text cells were grown
with 5 AM cathepsin B inhibitor Ca-074 Me (#205531,
Calbiochem) added to the medium.
Western blot analysis
For detection of E7 and p21 expression, cells were scraped
off the culture dish after incubation in RIPA buffer (1% NP-
40, 250 mM NaCl, 50 mM Tris–HCl, 10 mM DTT, 20 mM
NaF, 0.5 mM Na3VO4) at 4 jC for 10 min. The cell
suspension was sonicated and clarified by centrifugation at
15.000 g for 10 min. Samples of 20–40 Ag of total protein,
as determined by the Coomassie Plus Protein Assay (Pierce),
were loaded onto and separated by SDS-PAGE (Biorad) and
transferred to PVDF-membranes (Biorad). Membranes were
incubated overnight in PBS containing 1% nonfat dry milk
(Becton Dickinson) and 0.05% Tween-20 (Sigma). The
membranes were probed with antibodies against HPV-16
E7 (monoclonal antibody #ED17, Santa Cruz Biotechnolo-
gy) and p21 (DCS-61) (Thullberg et al., 2000) followed by
two-step secondary antibody detection (DAKO) and ECL
(Amersham). For detection of cathepsin B, PARP (poly-
(ADP-ribose)-polymerase), and caspases, 2  106 cells were
seeded in 85-mm dishes and grown for up to 96 h. To collect
apoptotic cells, the culture medium was centrifuged at 1500
rpm on ice. Following cell scraping, the adherent cells were
collected. Cells were washed in 2  5 ml cold PBS. Cells
were lysed in 300 Al cold RIPA buffer containing protease
inhibitors (complete tablets w/o EDTA, Roche). Samples
were sonicated 5 s on ice and centrifuged at 15.000  g for
10 min at 4 jC. Protein levels of the samples were determined
by the Coomassie Plus Protein Assay (Pierce). Proteins were
separated by SDS-PAGE (Biorad) and transferred to Hybond
nitrocellulose membranes (Amersham). Membranes were
blocked for 30 min in PBS containing 5% nonfat dry milk.
Membranes were probed overnight with antibodies to ca-
thepsin B (# 06–480, Upstate Biotechnology Inc., NY, USA,
or cathepsin B-specific rabbit polyclonal antibody kindly
provided by Dr. E. Weber, Martin Luther Universita¨t,
Halle-Wittenberg, Germany), PARP (#33-3100, Zymed Lab-
oratories Inc., S.F., CA, USA), caspase-1 (#AB1871, Chem-
icon Int.), caspase-3 (#556425, BD Biosciences), caspase-7
(#551236, BD Biosciences), caspase-8 (#551242, BD Bio-
sciences), caspase-9 (#551246, BD Biosciences), or GAPDH
(Biogenesis) followed by two-step secondary antibody de-
tection (DAKO) and ECL (Amersham).Co-immunoprecipitation analysis of E7 and pRB
Cells were collected and incubated in lysis buffer as
described above, but supplemented with 0.1% (v/v) Triton
X 100 (Sigma) instead of NP40. The lysates were incubated
10 min on ice and centrifuged at 20.000  g for 10 min.
Total protein samples (500 Ag) were added 5 Al of E7-
specific polyclonal rabbit immunoglobulins, provided by
Dr. D. Galloway, University of Washington, Seattle. After
1 h of incubation at 4 jC, 5 Al of swine anti-rabbit IgG (No
Z0196, DAKO) was added, and incubation was continued
for 30 min. Protein-A Sepharose was added (Amersham-
Pharmacia) and the sample was incubated over night at
4 jC. Immunoprecipitates were pelleted and washed twice
in PBS and resuspended in 60 Al of loading buffer (5%
glycerol, 2% SDS, 0.15 g DTT, 0.12 M TRIS–HCl, pH 6.8,
0.002% bromophenol blue). The co-precipitation was visu-
alized by Western blot analysis after probing of the mem-
brane with antibodies to pRB (G3-245, PharMingen, BD
Biosciences) used in the dilution recommended by the
manufacturer.
Immunofluorescence analysis
For detection of E7 and p21, E7/p21 cells were seeded in
8-well chambers (Nunc) in medium without tetracycline,
which induced protein synthesis. Cells were induced for 48
h and fixed in 4% paraformaldehyde (Fluka Chemie) for 10
min at room temperature. Cells were permeabilized in PBS
containing 0.2% NP40 (Sigma) and further incubated for 1
h at room temperature with a mixture of polyclonal rabbit
IgG to E7 and mouse monoclonal antibodies to the HA-tag
(#F-7, Santa Cruz) diluted in PBS with 1% nonfat dry milk
and 0.2% NP40. Finally, the cells were incubated for 20 min
with a mixture of FITC-conjugated swine-anti-rabbit IgG
(#F205, DAKO) and Cy-3 conjugated sheep-anti-mouse
IgG (#C2181, Sigma) diluted in PBS nonfat dry milk and
NP40 as above. All antibodies were used in dilutions
recommended by the manufacturer. Noninduced cells served
as controls. For detection of cathepsin B, cells were seeded
on 8-well plastic slides (Nunc) and fixed in ice-cold meth-
anol for 10 min. To permeabilize the cells and block
unspecific immunoreactivity, diluting buffer (1% BSA,
0.3% Triton X 100 in PBS) containing 5% swine serum
(DAKO) was added for 30 min. Primary antibodies (ca-
thepsin B-specific rabbit serum provided by Dr. E. Weber)
or unspecific rabbit serum (DAKO) diluted 1:500 in diluting
buffer were added to the cells followed by overnight
incubation at 4 jC. The cells were washed 3  10 min in
washing buffer (PBS containing 0.25% BSA and 0.1%
Triton X 100). Secondary antibodies (biotinylated swine
anti-rabbit immunoglobulins (DAKO)) diluted 1:500 in
diluting buffer were applied for 1 h at room temperature.
Cells were washed for 3  10 min in washing buffer.
Finally, steptavidine Oregon Green 488 (Molecular probes)
diluted 1:200 in diluting buffer was applied for 1 h at room
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buffer. In both experiments, the slides were coverslipped
with fluoromount (DAKO). Images were recorded with a
Nikon Diaphot 200 confocal microscope.
TUNEL assay for apoptosis
Apoptotic cells were identified by the TUNEL method
using the ApoAlert DNA Fragmentation Assay Kit (Clon-
tech). Cells were seeded to 70% confluence on coverslips
(Nunc). Seeding cells in medium without tetracycline lead
to induction of protein expression from the transgenes
whereas cells seeded in medium containing tetracycline
served as controls. The cathepsin B inhibitor Ca-074 Me
(#205531, Calbiochem) was used to verify the specificity
of the apoptotic signal. Cells were fixed in 4% parafor-
maldehyde and permeabilized in PBS containing 0.2% of
Triton X 100 (Sigma). Slides were coverslipped with
anti-fade mounting media (DAKO). Apoptotic cells were
visualized with a Leitz orthomate microscope using a
standard fluorescein filter (520 F 20 nm) (Leitz Wetzlar).
The fraction of TUNEL-positive cells was determined out
of 150 randomly selected cells. When the effect of
cathepsin B inhibitor Ca-074 Me was analyzed, the
fraction of TUNEL positive cells was determined out of
200 randomly selected cells.
Detection of apoptosis by flow cytometry
Detection of apoptotic cells was performed at 24, 48, 72,
and 96 h after induction of gene expression. Cell cultures
were trypsinized and free cells were labeled with annexin V-
FITC and propidium iodide (PI) by the use of ‘‘Apoptosis
Detection Kit’’ (R&D Systems) according to the manufac-
turers instructions. Annexin V binds to phosphotidylserine
present on the outside of the plasma membrane of apoptotic
cells, while PI gain entrance to late apoptotic and necrotic
cells. Percentages of apoptotic cells were calculated by
registration of annexin V labeled cells. Analysis was per-
formed by the use of a FACS Calibur apparatus and Cell
Quest software (Becton Dickinson, BD Biosciences), and
104 events were collected for analysis. Debris was excluded
from the analysis by electronic gating.
BrdU incorporation assay
The BrdU-ELISA (bromodeoxyuridine) assay (kit
#RPN250, Amersham) was performed by plating 5 
103 cells per well in 96-well plates (Nunc). After
indicated time points at normal culture conditions, BrdU
was added to a final concentration of 10 AM. After
another 24 h of incubation, the amount of incorporated
BrdU was detected according to the procedure recom-
mended by the manufacturer. The DNA replication was
determined as BrdU incorporation per milligram of total
protein in all experiments.Protein determination for growth curves
Cells were grown on 85-mm dishes for indicated time
points at normal cell culture conditions. Following the
harvest of the cells, they were lysed in RIPA buffer. Protein
determination of the samples was done by the Coomassie
Plus Protein Assay (Pierce) according to instructions from
the manufacturer.
MTT viability assay
The MTT ((3-(4,5-dimethylthizolyl-2)-2,5-diphenyltetra-
zolium bromide), Sigma) assay was set up by plating 104
newly induced cells per well in 96-well plates (Nunc). Cells
were grown in 100 Al medium without phenol red (Life
Technologies). At each time-point, 25 Al MTT (0.5% MTT
in PBS) was added to each well and the cells were incubated
for 4 h at 37 jC. After incubation, plates were stored at 80
jC. Before measuring, 100 Al solubilization buffer (20%
SDS, 50% N,N-dimethylformamide) was added to each well
and samples were incubated over night at room temperature
in darkness. Final measuring was performed by reading
samples at 570 nm for 0.1 s per well in a Wallac Victor multi
label counter.
Caspase assay
Caspase-3 activity was measured using the ApoAlertR
Caspase-3 kit (Clontech K2027) according to the protocol
given by the supplier. In brief, cells were harvested at
different time after E7/p21 or p21 induction. Control and
induced cells (2  106) were solubilized and used in each
assay. The supernatant was incubated with the DEVD-pNA
( p-nitroanilide) substrate, applied to microtiter plates, and
the color development was measured at 405 nm in a
spectrophotometer after 1 h of incubation at 37 jC. The
topoisomerase inhibitors etoposide (Sigma, 20 Ag/ml) and
camptothecin (Sigma, 10 AM) were used as positive con-
trols. The caspase-3 inhibitor DEVD-fmk was used for
control of specificity of the reaction.
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